Galapagos CEO Henry Gosebruch says the recent uptick in M&A activity is a positive development for the biotech as it pursues ...
Alvotech and Advanz Pharma have announced the European Commission’s (EC) marketing authorisations for Gobivaz, a biosimilar ...
US-based Aspen Neuroscience has closed a Series C funding round, raising $115m to further the clinical development of its ...
Though CMC barriers remain, strategic planning in the early development stages can guide a CGT product to success, noted ...
Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.
Moderna is to expand its US manufacturing capabilities with the onshoring of drug product manufacture to its existing Moderna ...
Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.
Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.
Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...
Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...
The fund will participate in follow-on and initial rounds, focusing on biotech and medtech ventures across core markets.
The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results